Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Improving Hypertension Control in East and Central Harlem
This study has been completed.
Sponsors and Collaborators: Mount Sinai School of Medicine
Agency for Healthcare Research and Quality (AHRQ)
Information provided by: Mount Sinai School of Medicine
ClinicalTrials.gov Identifier: NCT00211666
  Purpose

This hypertension project is evaluating strategies developed to target problems underlying lack of blood pressure control among treated but uncontrolled hypertensive patients in East and Central Harlem.


Condition Intervention
Hypertension
Behavioral: Nurse management, home blood pressure monitors, and a chronic disease self management course.

MedlinePlus related topics: High Blood Pressure
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title: Improving the Delivery of Effective Care to Minorities

Further study details as provided by Mount Sinai School of Medicine:

Primary Outcome Measures:
  • Differences in blood pressure reduction among the four study arms.

Secondary Outcome Measures:
  • Quality of life
  • patient satisfaction
  • costs
  • cost-effectiness

Estimated Enrollment: 480
Study Start Date: September 2002
Estimated Study Completion Date: August 2006
Detailed Description:

The hypertension project will tailor improvement strategies to the problems identified as underlying underuse among treated but uncontrolled hypertensive patients in East and Central Harlem, New York City. Along with the communities’ 6 major health providers, we will first combine qualitative and quantitative methods to identify specific patient, provider, and system problems, and customize interventions to address them. In a randomized controlled trial, we will then randomly assign 480 patients among 4 arms: nurse management, blood pressure monitors alone, usual care, and peer led chronic disease self-management course. During the 18-month trial, patients self-monitor their blood pressure or attend a self-management course, or nurse managers will assess patients’ needs, counsel them, address any access barriers, and follow up with regular telephone contacts; convey information, including blood pressures from patients’ self-monitoring, between patients and physicians to inform possible medication changes; and ameliorate any systems problems. We will assess differences in blood pressure reductions among the 4 arms as the primary outcome, and in quality of life, patient satisfaction, costs, and cost-effectiveness as secondary outcomes. The findings will provide new knowledge about the relationship between these changes and patient and clinician knowledge, attitudes, and behaviors. The educational course is designed to teach patients tools for managing their chronic illness which will empower them to improve their overall health and is specifically tailored for patients living with asymptomatic chronic illnesses and will emphasize communication with health care providers. In partnership with community organizations and the policymakers, we will disseminate successful findings within these communities and throughout the state and the nation.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Male and female, English or Spanish speaking African American and/or Hispanic patients with uncontrolled hypertension who have been seen in either the Cardiology clinic, Internal Medicine Associates (IMA) or Geriatric clinic at least twice in a given year at least 18 years of age.

Exclusion Criteria:

This study is about hypertension control among African Americans and Hispanics, these are the ethnic groups with disparities in CVD that we want to improve so other races are excluded. The study is for adults with hypertension; therefore, we are excluding anyone who is under 18 years of age.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00211666

Locations
United States, New York
Mount Sinai School of Medicine
New York, New York, United States, 10029
Sponsors and Collaborators
Mount Sinai School of Medicine
Investigators
Principal Investigator: Mark Chassin, MD Mount Sinai School of Medicine
  More Information

Study ID Numbers: P01 HS10859-05, 00-0053
Study First Received: September 13, 2005
Last Updated: September 13, 2005
ClinicalTrials.gov Identifier: NCT00211666  
Health Authority: United States: Institutional Review Board

Keywords provided by Mount Sinai School of Medicine:
Hypertension
blood pressure
self management
nurse management
racial disparities
cardiovascular disease

Study placed in the following topic categories:
Vascular Diseases
Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009